Legal Opinion
Joyce Fullington v. Pfizer, Inc.
Court of Appeals for the Eighth Circuit
Decided July 15, 2013No. 12-2945PublishedCited by 20 opinions
1Opinion of the Court
GRUENDER, Circuit Judge.
Joyce Fullington filed a product liability suit against the manufacturers of the prescription drug Reglan and its generic equivalent, metoclopramide. The district court ruled that all of Fullington’s claims were either not viable under Arkansas law or were preempted by federal law governing drug product labeling. We affirm in part, reverse in part, and remand for further consideration.
I. Background
From April 2008 through April 2009, Fullington ingested the prescription drug metoclopramide. She subsequently developed a neurological disorder called tardive dyskinesia,…
2Cases cited13 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
- Hamilton v. PalmCourt of Appeals for the Eighth Circuit · 2010
- Alvin L. Phipps v. Guaranty Natl. BankCourt of Appeals for the Eighth Circuit · 2005
- Berkeley Pump Co. v. Reed-Joseph Land Co.Supreme Court of Arkansas · 1983
8 more not listed; retrieve them via the Exa API.
3Cited by20 opinions
- Arthur Drager v. PLIVA USACourt of Appeals for the Fourth Circuit · 2014
- Schrock v. Wyeth, Inc.Court of Appeals for the Tenth Circuit · 2013
- Sarah Speed v. Wyeth Pharmaceuticals, Inc.Court of Appeals for the Sixth Circuit · 2013
- Jerry Cook v. George's, Inc.Court of Appeals for the Eighth Circuit · 2020
- Shirley Brinkley v. Pliva, Inc.Court of Appeals for the Eighth Circuit · 2014
15 more not listed; retrieve them via the Exa API.